IBDEI1NJ ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,26378,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,26378,1,3,0)
;;=3^DM Type 1 w/o Compl
;;^UTILITY(U,$J,358.3,26378,1,4,0)
;;=4^E10.9
;;^UTILITY(U,$J,358.3,26378,2)
;;=^5002626
;;^UTILITY(U,$J,358.3,26379,0)
;;=E10.620^^107^1240^5
;;^UTILITY(U,$J,358.3,26379,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,26379,1,3,0)
;;=3^DM Type 1 w/ Diab Dermatitis
;;^UTILITY(U,$J,358.3,26379,1,4,0)
;;=4^E10.620
;;^UTILITY(U,$J,358.3,26379,2)
;;=^5002615
;;^UTILITY(U,$J,358.3,26380,0)
;;=E10.36^^107^1240^4
;;^UTILITY(U,$J,358.3,26380,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,26380,1,3,0)
;;=3^DM Type 1 w/ Diab Cataract
;;^UTILITY(U,$J,358.3,26380,1,4,0)
;;=4^E10.36
;;^UTILITY(U,$J,358.3,26380,2)
;;=^5002602
;;^UTILITY(U,$J,358.3,26381,0)
;;=E10.621^^107^1240^6
;;^UTILITY(U,$J,358.3,26381,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,26381,1,3,0)
;;=3^DM Type 1 w/ Diab Foot Ulcer
;;^UTILITY(U,$J,358.3,26381,1,4,0)
;;=4^E10.621
;;^UTILITY(U,$J,358.3,26381,2)
;;=^5002616
;;^UTILITY(U,$J,358.3,26382,0)
;;=E10.622^^107^1240^28
;;^UTILITY(U,$J,358.3,26382,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,26382,1,3,0)
;;=3^DM Type 1 w/ Oth Skin Ulcer
;;^UTILITY(U,$J,358.3,26382,1,4,0)
;;=4^E10.622
;;^UTILITY(U,$J,358.3,26382,2)
;;=^5002617
;;^UTILITY(U,$J,358.3,26383,0)
;;=E10.51^^107^1240^32
;;^UTILITY(U,$J,358.3,26383,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,26383,1,3,0)
;;=3^DM Type 1 w/ Periph Angiopathy w/o Gangrene
;;^UTILITY(U,$J,358.3,26383,1,4,0)
;;=4^E10.51
;;^UTILITY(U,$J,358.3,26383,2)
;;=^5002610
;;^UTILITY(U,$J,358.3,26384,0)
;;=E10.52^^107^1240^31
;;^UTILITY(U,$J,358.3,26384,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,26384,1,3,0)
;;=3^DM Type 1 w/ Periph Angiopathy w/ Gangrene
;;^UTILITY(U,$J,358.3,26384,1,4,0)
;;=4^E10.52
;;^UTILITY(U,$J,358.3,26384,2)
;;=^5002611
;;^UTILITY(U,$J,358.3,26385,0)
;;=E11.00^^107^1241^19
;;^UTILITY(U,$J,358.3,26385,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,26385,1,3,0)
;;=3^DM Type 2 w/ Hyperosmolarity w/o NKHHC
;;^UTILITY(U,$J,358.3,26385,1,4,0)
;;=4^E11.00
;;^UTILITY(U,$J,358.3,26385,2)
;;=^5002627
;;^UTILITY(U,$J,358.3,26386,0)
;;=E11.01^^107^1241^18
;;^UTILITY(U,$J,358.3,26386,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,26386,1,3,0)
;;=3^DM Type 2 w/ Hyperosmolarity w/ Coma
;;^UTILITY(U,$J,358.3,26386,1,4,0)
;;=4^E11.01
;;^UTILITY(U,$J,358.3,26386,2)
;;=^5002628
;;^UTILITY(U,$J,358.3,26387,0)
;;=E11.21^^107^1241^7
;;^UTILITY(U,$J,358.3,26387,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,26387,1,3,0)
;;=3^DM Type 2 w/ Diab Nephropathy
;;^UTILITY(U,$J,358.3,26387,1,4,0)
;;=4^E11.21
;;^UTILITY(U,$J,358.3,26387,2)
;;=^5002629
;;^UTILITY(U,$J,358.3,26388,0)
;;=E11.22^^107^1241^3
;;^UTILITY(U,$J,358.3,26388,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,26388,1,3,0)
;;=3^DM Type 2 w/ Diab CKD
;;^UTILITY(U,$J,358.3,26388,1,4,0)
;;=4^E11.22
;;^UTILITY(U,$J,358.3,26388,2)
;;=^5002630
;;^UTILITY(U,$J,358.3,26389,0)
;;=E11.39^^107^1241^28
;;^UTILITY(U,$J,358.3,26389,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,26389,1,3,0)
;;=3^DM Type 2 w/ Oth Diab Ophth Compl
;;^UTILITY(U,$J,358.3,26389,1,4,0)
;;=4^E11.39
;;^UTILITY(U,$J,358.3,26389,2)
;;=^5002643
;;^UTILITY(U,$J,358.3,26390,0)
;;=E11.41^^107^1241^6
;;^UTILITY(U,$J,358.3,26390,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,26390,1,3,0)
;;=3^DM Type 2 w/ Diab Mononeuropathy
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI1NJ 3816 printed Apr 09, 2024@21:09:37 Page 2
IBDEI1NJ ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,26378,1,0)
+2 ;;=^358.31IA^4^2
+3 ;;^UTILITY(U,$J,358.3,26378,1,3,0)
+4 ;;=3^DM Type 1 w/o Compl
+5 ;;^UTILITY(U,$J,358.3,26378,1,4,0)
+6 ;;=4^E10.9
+7 ;;^UTILITY(U,$J,358.3,26378,2)
+8 ;;=^5002626
+9 ;;^UTILITY(U,$J,358.3,26379,0)
+10 ;;=E10.620^^107^1240^5
+11 ;;^UTILITY(U,$J,358.3,26379,1,0)
+12 ;;=^358.31IA^4^2
+13 ;;^UTILITY(U,$J,358.3,26379,1,3,0)
+14 ;;=3^DM Type 1 w/ Diab Dermatitis
+15 ;;^UTILITY(U,$J,358.3,26379,1,4,0)
+16 ;;=4^E10.620
+17 ;;^UTILITY(U,$J,358.3,26379,2)
+18 ;;=^5002615
+19 ;;^UTILITY(U,$J,358.3,26380,0)
+20 ;;=E10.36^^107^1240^4
+21 ;;^UTILITY(U,$J,358.3,26380,1,0)
+22 ;;=^358.31IA^4^2
+23 ;;^UTILITY(U,$J,358.3,26380,1,3,0)
+24 ;;=3^DM Type 1 w/ Diab Cataract
+25 ;;^UTILITY(U,$J,358.3,26380,1,4,0)
+26 ;;=4^E10.36
+27 ;;^UTILITY(U,$J,358.3,26380,2)
+28 ;;=^5002602
+29 ;;^UTILITY(U,$J,358.3,26381,0)
+30 ;;=E10.621^^107^1240^6
+31 ;;^UTILITY(U,$J,358.3,26381,1,0)
+32 ;;=^358.31IA^4^2
+33 ;;^UTILITY(U,$J,358.3,26381,1,3,0)
+34 ;;=3^DM Type 1 w/ Diab Foot Ulcer
+35 ;;^UTILITY(U,$J,358.3,26381,1,4,0)
+36 ;;=4^E10.621
+37 ;;^UTILITY(U,$J,358.3,26381,2)
+38 ;;=^5002616
+39 ;;^UTILITY(U,$J,358.3,26382,0)
+40 ;;=E10.622^^107^1240^28
+41 ;;^UTILITY(U,$J,358.3,26382,1,0)
+42 ;;=^358.31IA^4^2
+43 ;;^UTILITY(U,$J,358.3,26382,1,3,0)
+44 ;;=3^DM Type 1 w/ Oth Skin Ulcer
+45 ;;^UTILITY(U,$J,358.3,26382,1,4,0)
+46 ;;=4^E10.622
+47 ;;^UTILITY(U,$J,358.3,26382,2)
+48 ;;=^5002617
+49 ;;^UTILITY(U,$J,358.3,26383,0)
+50 ;;=E10.51^^107^1240^32
+51 ;;^UTILITY(U,$J,358.3,26383,1,0)
+52 ;;=^358.31IA^4^2
+53 ;;^UTILITY(U,$J,358.3,26383,1,3,0)
+54 ;;=3^DM Type 1 w/ Periph Angiopathy w/o Gangrene
+55 ;;^UTILITY(U,$J,358.3,26383,1,4,0)
+56 ;;=4^E10.51
+57 ;;^UTILITY(U,$J,358.3,26383,2)
+58 ;;=^5002610
+59 ;;^UTILITY(U,$J,358.3,26384,0)
+60 ;;=E10.52^^107^1240^31
+61 ;;^UTILITY(U,$J,358.3,26384,1,0)
+62 ;;=^358.31IA^4^2
+63 ;;^UTILITY(U,$J,358.3,26384,1,3,0)
+64 ;;=3^DM Type 1 w/ Periph Angiopathy w/ Gangrene
+65 ;;^UTILITY(U,$J,358.3,26384,1,4,0)
+66 ;;=4^E10.52
+67 ;;^UTILITY(U,$J,358.3,26384,2)
+68 ;;=^5002611
+69 ;;^UTILITY(U,$J,358.3,26385,0)
+70 ;;=E11.00^^107^1241^19
+71 ;;^UTILITY(U,$J,358.3,26385,1,0)
+72 ;;=^358.31IA^4^2
+73 ;;^UTILITY(U,$J,358.3,26385,1,3,0)
+74 ;;=3^DM Type 2 w/ Hyperosmolarity w/o NKHHC
+75 ;;^UTILITY(U,$J,358.3,26385,1,4,0)
+76 ;;=4^E11.00
+77 ;;^UTILITY(U,$J,358.3,26385,2)
+78 ;;=^5002627
+79 ;;^UTILITY(U,$J,358.3,26386,0)
+80 ;;=E11.01^^107^1241^18
+81 ;;^UTILITY(U,$J,358.3,26386,1,0)
+82 ;;=^358.31IA^4^2
+83 ;;^UTILITY(U,$J,358.3,26386,1,3,0)
+84 ;;=3^DM Type 2 w/ Hyperosmolarity w/ Coma
+85 ;;^UTILITY(U,$J,358.3,26386,1,4,0)
+86 ;;=4^E11.01
+87 ;;^UTILITY(U,$J,358.3,26386,2)
+88 ;;=^5002628
+89 ;;^UTILITY(U,$J,358.3,26387,0)
+90 ;;=E11.21^^107^1241^7
+91 ;;^UTILITY(U,$J,358.3,26387,1,0)
+92 ;;=^358.31IA^4^2
+93 ;;^UTILITY(U,$J,358.3,26387,1,3,0)
+94 ;;=3^DM Type 2 w/ Diab Nephropathy
+95 ;;^UTILITY(U,$J,358.3,26387,1,4,0)
+96 ;;=4^E11.21
+97 ;;^UTILITY(U,$J,358.3,26387,2)
+98 ;;=^5002629
+99 ;;^UTILITY(U,$J,358.3,26388,0)
+100 ;;=E11.22^^107^1241^3
+101 ;;^UTILITY(U,$J,358.3,26388,1,0)
+102 ;;=^358.31IA^4^2
+103 ;;^UTILITY(U,$J,358.3,26388,1,3,0)
+104 ;;=3^DM Type 2 w/ Diab CKD
+105 ;;^UTILITY(U,$J,358.3,26388,1,4,0)
+106 ;;=4^E11.22
+107 ;;^UTILITY(U,$J,358.3,26388,2)
+108 ;;=^5002630
+109 ;;^UTILITY(U,$J,358.3,26389,0)
+110 ;;=E11.39^^107^1241^28
+111 ;;^UTILITY(U,$J,358.3,26389,1,0)
+112 ;;=^358.31IA^4^2
+113 ;;^UTILITY(U,$J,358.3,26389,1,3,0)
+114 ;;=3^DM Type 2 w/ Oth Diab Ophth Compl
+115 ;;^UTILITY(U,$J,358.3,26389,1,4,0)
+116 ;;=4^E11.39
+117 ;;^UTILITY(U,$J,358.3,26389,2)
+118 ;;=^5002643
+119 ;;^UTILITY(U,$J,358.3,26390,0)
+120 ;;=E11.41^^107^1241^6
+121 ;;^UTILITY(U,$J,358.3,26390,1,0)
+122 ;;=^358.31IA^4^2
+123 ;;^UTILITY(U,$J,358.3,26390,1,3,0)
+124 ;;=3^DM Type 2 w/ Diab Mononeuropathy
